SABS - SAB Biotherapeutics Inc
3.79
-0.020 -0.528%
Share volume: 155,952
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.17%
PREVIOUS CLOSE
CHG
CHG%
$3.81
-0.02
-0.01%
Summary score
50%
Profitability
53%
Dept financing
25%
Liquidity
58%
Performance
51%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 30-Sep-2021 - 30-Sep-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-22.98%
Return on assets
-12.71%
Return on sales
-2127.9%
Return on invested capital
-50.59%
Total debt ratio
35.28%
Debt ratio change over timeo
-1.19%
Current Ratio
3.15%
Quick Ratio
2.2%
Cash Position Ratio
1.76%
Short-term ratios 30-Sep-2024 - 30-Sep-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
5.41%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
26.93%
Debt ratio change over timeo
0%
Current Ratio
6.09%
Quick Ratio
0%
Cash Position Ratio
1.66%
Last quarter ratios 30-Sep-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
24.44%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
10.02%
Debt ratio change over time
0%
Current Ratio
10.5%
Quick Ratio
0%
Cash Position Ratio
2.73%
Performance ratios (change over 4 years) 30-Sep-2021 - 30-Sep-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-65.48%
Return on assets
-82.54%
Return on sales
5473.56%
Return on invested capital
-20.56%
Total debt ratio
-119.27%
Debt ratio change over time
-1.19%
Current Ratio
-3.87%
Quick Ratio
-2.12%
Cash Position Ratio
-3.27%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | SABS | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | -22.98% | 28.34% | 5.51% | 6.15% |
| Return on assets | -12.71% | 3.06% | 3.18% | 2.21% |
| Return on sales | -2127.9% | 28.09% | 27.06% | 23.01% |
| Return on invested capital | -50.59% | 6.42% | 3.22% | 6.7% |
| Profitability | 0% | 98% | 66% | 68% |
| Total debt ratio | 35.28% | 93.19% | 66.22% | 44.66% |
| Debt ratio change over time | -1.19% | 12.76% | 169.64% | 13.01% |
| Dept financing | 9% | 27% | 43% | 14% |
| Current Ratio | 6.09% | 1.25% | 1.43% | 2% |
| Quick Ratio | 0% | 0.95% | 1.29% | 1.44% |
| Cash Position Ratio | 1.66% | 0.43% | 0.63% | 0.74% |
| Liquididy | 75% | 40% | 32% | 46% |
| Short-term ratios | SABS | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | 5.41% | 3.09% | 4.74% | 1.98% |
| Return on sales | 0% | 23.81% | 35.93% | 22.2% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 75% | 31% | 47% | 25% |
| Total debt ratio | 26.93% | 91.88% | 65.29% | 38.81% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 32% | 25% | 18% | 11% |
| Current Ratio | 6.09% | 1.25% | 1.43% | 2% |
| Quick Ratio | 0% | 0.95% | 1.29% | 1.44% |
| Cash Position Ratio | 1.66% | 0.43% | 0.63% | 0.74% |
| Liquididy | 50% | 28% | 38% | 44% |